BR112017017774A2 - compound, pharmaceutical composition and method of manufacturing a medicament - Google Patents

compound, pharmaceutical composition and method of manufacturing a medicament

Info

Publication number
BR112017017774A2
BR112017017774A2 BR112017017774A BR112017017774A BR112017017774A2 BR 112017017774 A2 BR112017017774 A2 BR 112017017774A2 BR 112017017774 A BR112017017774 A BR 112017017774A BR 112017017774 A BR112017017774 A BR 112017017774A BR 112017017774 A2 BR112017017774 A2 BR 112017017774A2
Authority
BR
Brazil
Prior art keywords
medicament
compound
manufacturing
pharmaceutical composition
kinetomyome
Prior art date
Application number
BR112017017774A
Other languages
Portuguese (pt)
Inventor
Placzek Andrew
Mathews Meinig James
Ferarra Sky
Banerji Tapasree
Scanlan Thomas
Original Assignee
Univ Oregon Health & Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oregon Health & Science filed Critical Univ Oregon Health & Science
Priority claimed from PCT/US2016/018732 external-priority patent/WO2016134292A1/en
Publication of BR112017017774A2 publication Critical patent/BR112017017774A2/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

são descritos derivados de éster de sobetiroma com distribuição cns melhorada.Enhanced distribution of the kinetomyome ester derivatives are described.

BR112017017774A 2015-02-20 2016-02-19 compound, pharmaceutical composition and method of manufacturing a medicament BR112017017774A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201561119001P 2015-02-20 2015-02-20
PCT/US2016/018732 WO2016134292A1 (en) 2015-02-20 2016-02-19 Derivatives of sobetirome

Publications (1)

Publication Number Publication Date
BR112017017774A2 true BR112017017774A2 (en) 2018-04-03

Family

ID=62107416

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017774A BR112017017774A2 (en) 2015-02-20 2016-02-19 compound, pharmaceutical composition and method of manufacturing a medicament

Country Status (1)

Country Link
BR (1) BR112017017774A2 (en)

Similar Documents

Publication Publication Date Title
EA201890126A1 (en) NEW BICYCLIC DERIVATIVES, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP3302426A4 (en) D2o stabilized pharmaceutical formulations
GEP20217239B (en) Pharmaceutical composition
DK3297605T3 (en) TOPIC, PHARMACEUTICAL COMPOSITIONS
BR112016021012A2 (en) pharmaceutical compositions of therapeutically active compounds.
DK3357491T3 (en) Pharmaceutical composition for the delivery of an anionic drug
DK3634468T3 (en) SOLID COMPOSITION FOR ORAL ADMINISTRATION
BR112016014880A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING PALONOSETRON
TR201821116A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING POSACONAZOL AND THE MANUFACTURING METHOD
EP3310439A4 (en) Pharmaceutical compositions for anesthesiological applications
BR112017000730B8 (en) PYRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS, AND DRUGS
GEP20217240B (en) Pharmaceutical composition
BR112017001221A2 (en) indolizine derivatives that are applicable to neurodegenerative diseases
EP3581183A4 (en) Tumor-treating pharmaceutical composition
EP3272362A4 (en) Sustained-release pharmaceutical composition
EP3275450A4 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containinglactococcus chungangensis
MA47516A (en) PHARMACEUTICAL COMPOSITION
TR201901228T4 (en) Vortioxetine pyroglutamate.
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
EP3402470A4 (en) Stable pharmaceutical composition
IN2014CH00840A (en)
EA201791716A1 (en) PHARMACEUTICAL COMPOSITION
EP3524250A4 (en) Pharmaceutical composition
EP3646867A4 (en) Pharmaceutical composition
BR112017001888A2 (en) biological formulations for intravesical instillation

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired